Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4825-4834

  Pan, Kao Lu ^a   Lee, Jin Ching ^b,c   Sung, Hsing Wen ^a   Chang, Teng Yuang ^c   Hsu, John T A ^c,d  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA INTERFERON; ANTIVIRUS AGENT; CD81 ANTIBODY; CILUPREVIR; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NARINGENIN; NONSTRUCTURAL PROTEIN 3; PROTEINASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME SUBSTRATE; HEPATITIS C; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ALKALINE PHOSPHATASE; ANTIVIRAL AGENTS; CARRIER PROTEINS; CELL LINE; GENES, REPORTER; HEPACIVIRUS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 70350315082     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00601-09     Document Type: Article

References (52)

1. Ahmed, M. M., T. H. Huang, and Q. D. Xie. 2008. A sensitive and rapid assay for investigating vertical transmission of hepatitis B virus via male germ line using EGFP vector as reporter. J. Biomed. Biotechnol. 2008:495436.
2. Blanchard, E., S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski, and Y. Rouille. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80:6964-6972. (Pubitemid 44025195)
3. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
4. Bourne, N., R. B. Pyles, M. Yi, R. L. Veselenak, M. M. Davis, and S. M. Lemon. 2005. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Antivir. Res. 67:76-82.
5. Cai, Z., C. Zhang, K. S. Chang, J. Jiang, B. C. Ahn, T. Wakita, T. J. Liang, and G. Luo. 2005. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79:13963-13973. (Pubitemid 41552695)
6. Chou, C. F., S. Shen, G. Mahadevappa, S. G. Lim, W. Hong, and Y. J. Tan. 2007. The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell-cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2. Anal. Biochem. 366:190-196.
7. Chow, W. A., C. Jiang, and M. Guan. 2009. Anti-HIV drugs for cancer therapeutics: back to the future? Lancet Oncol. 10:61-71.
8. Cory, A. H., T. C. Owen, J. A. Barltrop, and J. G. Cory. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:207-212.
9. Dansako, H., M. Ikeda, K. Abe, K. Mori, K. Takemoto, Y. Ariumi, and N. Kato. 2008. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication. Virus Res. 137:72-79.
10. Farquhar, M. J., H. J. Harris, M. Diskar, S. Jones, C. J. Mee, S. U. Nielsen, C. L. Brimacombe, S. Molina, G. L. Toms, P. Maurel, J. Howl, F. W. Herberg, S. C. van Ijzendoorn, P. Balfe, and J. A. McKeating. 2008. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J. Virol. 82:8797-8811.
11. Gallinari, P., D. Brennan, C. Nardi, M. Brunetti, L. Tomei, C. Steinkuhler, and R. De Francesco. 1998. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J. Virol. 72:6758-6769. (Pubitemid 28323995)
12. Gottwein, J. M., T. K. Scheel, A. M. Hoegh, J. B. Lademann, J. Eugen-Olsen, G. Lisby, and J. Bukh. 2007. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133:1614-1626.
13. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. USA 90:10583-10587.
14. Grum-Tokars, V., K. Ratia, A. Begaye, S. C. Baker, and A. D. Mesecar. 2008. Evaluating the 3C-like protease activity of SARS-coronavirus: recommendations for standardized assays for drug discovery. Virus Res. 133:63-73.
15. Hao, W., and R. Duggal. 2009. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system. Methods Mol. Biol. 510:243-250.
16. Hao, W., K. J. Herlihy, N. J. Zhang, S. A. Fuhrman, C. Doan, A. K. Patick, and R. Duggal. 2007. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening. Antimicrob. Agents Chemother. 51:95-102.
17. Hwang, D. R., R. K. Lin, G. Z. Leu, T. Y. Lin, T. W. Lien, M. C. Yu, C. T. Yeh, and J. T. Hsu. 2005. Inhibition of hepatitis C virus replication by antimonial compounds. Antimicrob. Agents Chemother. 49:4197-4202.
18. Hwang, D. R., Y. C. Tsai, J. C. Lee, K. K. Huang, R. K. Lin, C. H. Ho, J. M. Chiou, Y. T. Lin, J. T. Hsu, and C. T. Yeh. 2004. Inhibition of hepatitis C virus replication by arsenic trioxide. Antimicrob. Agents Chemother. 48:2876-2882.
19. Hwang, D. R., Y. S. Wu, C. W. Chang, T. W. Lien, W. C. Chen, U. K. Tan, J. T. Hsu, and H. P. Hsieh. 2006. Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system. Bioorg. Med. Chem. 14:83-91.
20. Ikeda, M., K. Abe, H. Dansako, T. Nakamura, K. Naka, and N. Kato. 2005. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Commun. 329:1350-1359.
21. Iro, M., J. Witteveldt, A. G. Angus, I. Woerz, A. Kaul, R. Bartenschlager, and A. H. Patel. 2009. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antivir. Res. 83:148-155.
22. Jones, C. T., C. L. Murray, D. K. Eastman, J. Tassello, and C. M. Rice. 2007. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81:8374-8383. (Pubitemid 47242811)
23. Jung, E. Y., M. N. Lee, H. Y. Yang, D. Yu, and K. L. Jang. 2001. The repressive activity of hepatitis C virus core protein on the transcription of p21waf1 is regulated by protein kinase A-mediated phosphorylation. Virus Res. 79:109-115.
24. Kato, N. 2001. Molecular virology of hepatitis C virus. Acta Med. Okayama 55:133-159.
25. Kim, C. S., J. H. Jung, T. Wakita, S. K. Yoon, and S. K. Jang. 2007. Monitoring the antiviral effect of alpha interferon on individual cells. J. Virol. 81:8814-8820.
26. Kolykhalov, A. A., K. Mihalik, S. M. Feinstone, and C. M. Rice. 2000. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74:2046-2051.
27. Koutsoudakis, G., A. Kaul, E. Steinmann, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80:5308-5320. (Pubitemid 43752776)
28. Lamarre, D., P. C. Anderson, M. Bailey, P. Beaulieu, G. Bolger, P. Bonneau, M. Bos, D. R. Cameron, M. Cartier, M. G. Cordingley, A. M. Faucher, N. Goudreau, S. H. Kawai, G. Kukolj, L. Lagace, S. R. LaPlante, H. Narjes, M. A. Poupart, J. Rancourt, R. E. Sentjens, R. St. George, B. Simoneau, G. Steinmann, D. Thibeault, Y. S. Tsantrizos, S. M. Weldon, C. L. Yong, and M. Llinas-Brunet. 2003. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186-189. (Pubitemid 37442587)
29. Lee, J. C., C. F. Chang, Y. H. Chi, D. R. Hwang, and J. T. Hsu. 2004. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells. J. Virol. Methods 116:27-33.
30. Lee, J. C., Y. F. Shih, S. P. Hsu, T. Y. Chang, L. H. Chen, and J. T. Hsu. 2003. Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells. Anal. Biochem. 316:162-170.
31. Lee, J. C., M. C. Yu, T. W. Lien, C. F. Chang, and J. T. Hsu. 2005. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors. Assay Drug Dev. Technol 3:385-392. (Pubitemid 41489394)
32. Leu, G. Z., T. Y. Lin, and J. T. Hsu. 2004. Anti-HCV activities of selective polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 318:275-280.
33. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. (Pubitemid 41033648)
34. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113. (Pubitemid 29307577)
35. McKerrow, J. H., P. J. Rosenthal, R. Swenerton, and P. Doyle. 2008. Development of protease inhibitors for protozoan infections. Curr. Opin. Infect. Dis. 21:668-672.
36. Nahmias, Y., J. Goldwasser, M. Casali, D. van Poll, T. Wakita, R. T. Chung, and M. L. Yarmush. 2008. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 47:1437-1445. (Pubitemid 351702727)
37. Owsianka, A. M., J. M. Timms, A. W. Tarr, R. J. Brown, T. P. Hickling, A. Szwejk, K. Bienkowska-Szewczyk, B. J. Thomson, A. H. Patel, and J. K. Ball. 2006. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J. Virol. 80:8695-8704.
38. Penin, F., J. Dubuisson, F. A. Rey, D. Moradpour, and J. M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39:5-19.
39. Schaller, T., N. Appel, G. Koutsoudakis, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager. 2007. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81:4591-4603. (Pubitemid 46668657)
40. Scheel, T. K., J. M. Gottwein, T. B. Jensen, J. C. Prentoe, A. M. Hoegh, H. J. Alter, J. Eugen-Olsen, and J. Bukh. 2008. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc. Natl. Acad. Sci. USA 105:997-1002.
41. Soriano, V., M. G. Peters, and S. Zeuzem. 2009. New therapies for hepatitis C virus infection. Clin. Infect. Dis. 48:313-320.
42. Tan, S. L., A. Pause, Y. Shi, and N. Sonenberg. 2002. Hepatitis C therapeutics: current status and emerging strategies. Nat. Rev. Drug Discov. 1:867-881.
43. Thomas, D. L. 2000. Hepatitis C epidemiology. Curr. Top. Microbiol. Immunol. 242:25-41.
44. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
45. Yang, Y., J. Kitagaki, H. Wang, D. X. Hou, and A. O. Perantoni. 2009. Targeting the ubiquitin-proteasome system for cancer therapy. Cancer Sci. 100:24-28.
46. Yi, M., Y. Ma, J. Yates, and S. M. Lemon. 2007. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 81:629-638.
47. Yi, M., R. A. Villanueva, D. L. Thomas, T. Wakita, and S. M. Lemon. 2006. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. USA 103:2310-2315.
48. Yu, X., B. Sainz, Jr., and S. L. Uprichard. 20 July 2009. Development of a cell-based hepatitis C virus (HCV) infection FRET assay for high-throughput antiviral compound screening. Antimicrob. Agents Chemother. doi: 10.1128/AAC.00495-09.
49. Zhang, J. H., T. D. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.
50. Zhang, Y., P. Weady, R. Duggal, and W. Hao. 2008. Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening. Antimicrob. Agents Chemother. 52:666-674.
51. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102:9294-9299.
52. Zuck, P., E. M. Murray, E. Stec, J. A. Grobler, A. J. Simon, B. Strulovici, J. Inglese, O. A. Flores, and M. Ferrer. 2004. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication. Anal. Biochem. 334:344-355.